nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—SLC2A1—endothelium—atherosclerosis	0.0398	0.243	CbGeAlD
Etomidate—SLC2A1—blood vessel—atherosclerosis	0.0367	0.224	CbGeAlD
Etomidate—SLC2A1—connective tissue—atherosclerosis	0.0188	0.115	CbGeAlD
Etomidate—SLC2A1—cardiovascular system—atherosclerosis	0.0164	0.0998	CbGeAlD
Etomidate—SLC2A1—adipose tissue—atherosclerosis	0.0144	0.088	CbGeAlD
Etomidate—CYP11B2—cardiovascular system—atherosclerosis	0.014	0.0855	CbGeAlD
Etomidate—SLC2A1—liver—atherosclerosis	0.0101	0.0617	CbGeAlD
Etomidate—CYP19A1—connective tissue—atherosclerosis	0.00595	0.0363	CbGeAlD
Etomidate—CYP19A1—adipose tissue—atherosclerosis	0.00457	0.0278	CbGeAlD
Etomidate—Pseudoephedrine—TNF—atherosclerosis	0.00415	0.374	CrCbGaD
Etomidate—CYP19A1—liver—atherosclerosis	0.0032	0.0195	CbGeAlD
Etomidate—Fenoprofen—PTGS2—atherosclerosis	0.00271	0.244	CrCbGaD
Etomidate—Fenoprofen—ALB—atherosclerosis	0.00241	0.217	CrCbGaD
Etomidate—Pethidine—ALB—atherosclerosis	0.00182	0.164	CrCbGaD
Etomidate—CYP11B2—Metabolism—ABCA1—atherosclerosis	0.000321	0.000389	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.00032	0.000387	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CNR2—atherosclerosis	0.000318	0.000385	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.000318	0.000385	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—ALB—atherosclerosis	0.000316	0.000383	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—EDN1—atherosclerosis	0.000315	0.000382	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—FABP4—atherosclerosis	0.000314	0.000381	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—LCAT—atherosclerosis	0.000314	0.000381	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CCL5—atherosclerosis	0.000313	0.000379	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SOD1—atherosclerosis	0.000311	0.000377	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CX3CR1—atherosclerosis	0.00031	0.000376	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CASR—atherosclerosis	0.00031	0.000376	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—HMGCR—atherosclerosis	0.00031	0.000376	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.00031	0.000376	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APOA4—atherosclerosis	0.000309	0.000374	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CX3CL1—atherosclerosis	0.000304	0.000369	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP7A1—atherosclerosis	0.000303	0.000367	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—NOS3—atherosclerosis	0.000302	0.000366	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HRH1—atherosclerosis	0.000297	0.00036	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—APOB—atherosclerosis	0.000297	0.00036	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IGF2—atherosclerosis	0.000295	0.000358	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000293	0.000356	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000289	0.00035	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CNR2—atherosclerosis	0.000289	0.00035	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—APOB—atherosclerosis	0.000286	0.000347	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000284	0.000345	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000283	0.000343	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CXCL8—atherosclerosis	0.000281	0.000341	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP27A1—atherosclerosis	0.00028	0.00034	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.00028	0.000339	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ABCA1—atherosclerosis	0.000276	0.000335	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PTGS2—atherosclerosis	0.000276	0.000335	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000276	0.000334	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—HMOX1—atherosclerosis	0.000275	0.000333	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.000274	0.000332	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000271	0.000328	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000269	0.000326	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PRKCG—atherosclerosis	0.000266	0.000322	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ALOX15—atherosclerosis	0.000266	0.000322	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APOA2—atherosclerosis	0.000266	0.000322	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PLA2G2A—atherosclerosis	0.000266	0.000322	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ALOX5AP—atherosclerosis	0.000266	0.000322	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—APOB—atherosclerosis	0.000263	0.000319	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ABCG5—atherosclerosis	0.000262	0.000318	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000262	0.000318	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—AGT—atherosclerosis	0.000262	0.000317	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—CD36—atherosclerosis	0.00026	0.000315	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—APOB—atherosclerosis	0.000259	0.000314	CbGpPWpGaD
Etomidate—SLC2A1—Disease—STAT3—atherosclerosis	0.000257	0.000312	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000257	0.000311	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTM1—atherosclerosis	0.000256	0.000311	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—LPA—atherosclerosis	0.000253	0.000307	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—LPL—atherosclerosis	0.000252	0.000305	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.00025	0.000303	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCL3—atherosclerosis	0.000248	0.000301	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—EDNRA—atherosclerosis	0.000247	0.0003	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CCR2—atherosclerosis	0.000247	0.0003	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MAPK3—atherosclerosis	0.000246	0.000298	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—BGN—atherosclerosis	0.000245	0.000298	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GPX1—atherosclerosis	0.000245	0.000298	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000244	0.000295	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APOA5—atherosclerosis	0.000243	0.000295	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—F2—atherosclerosis	0.000242	0.000293	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GHRL—atherosclerosis	0.000241	0.000292	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	0.00024	0.000291	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PDGFB—atherosclerosis	0.00024	0.000291	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CD36—atherosclerosis	0.000239	0.00029	CbGpPWpGaD
Etomidate—SLC2A1—Disease—TGFB1—atherosclerosis	0.000238	0.000289	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—HMOX1—atherosclerosis	0.000237	0.000287	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—MMP1—atherosclerosis	0.000237	0.000287	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000236	0.000286	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000235	0.000285	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PLA2G1B—atherosclerosis	0.000234	0.000283	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APOA4—atherosclerosis	0.000233	0.000282	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000231	0.00028	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	0.00023	0.000279	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000229	0.000278	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000229	0.000278	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000229	0.000277	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—CAV1—atherosclerosis	0.000227	0.000275	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	0.000227	0.000275	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—APOB—atherosclerosis	0.000227	0.000275	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—APOA1—atherosclerosis	0.000227	0.000275	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—MTHFR—atherosclerosis	0.000226	0.000275	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ALOX5—atherosclerosis	0.000226	0.000274	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCR2—atherosclerosis	0.000224	0.000272	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—EDNRA—atherosclerosis	0.000224	0.000272	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000224	0.000271	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PPARA—atherosclerosis	0.000222	0.000269	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTM1—atherosclerosis	0.000221	0.000268	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	0.00022	0.000267	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.000219	0.000265	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GHRL—atherosclerosis	0.000219	0.000265	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—LPL—atherosclerosis	0.000217	0.000263	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—F2—atherosclerosis	0.000216	0.000262	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CCL2—atherosclerosis	0.000216	0.000261	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—AGT—atherosclerosis	0.000215	0.000261	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCL4—atherosclerosis	0.000215	0.00026	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NOS2—atherosclerosis	0.000214	0.000259	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GPX1—atherosclerosis	0.000211	0.000256	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—KNG1—atherosclerosis	0.000211	0.000256	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—APOE—atherosclerosis	0.000211	0.000256	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AGTR1—atherosclerosis	0.00021	0.000255	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CAV1—atherosclerosis	0.000209	0.000253	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000209	0.000253	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—APOA1—atherosclerosis	0.000208	0.000253	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PIK3CG—atherosclerosis	0.000207	0.000251	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CD36—atherosclerosis	0.000206	0.00025	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000205	0.000249	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000203	0.000247	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NAMPT—atherosclerosis	0.000203	0.000246	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000201	0.000244	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—LIPC—atherosclerosis	0.000201	0.000244	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APOA2—atherosclerosis	0.000201	0.000243	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APOC3—atherosclerosis	0.0002	0.000243	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—LDLR—atherosclerosis	0.000199	0.000241	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—MTHFR—atherosclerosis	0.000195	0.000237	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CETP—atherosclerosis	0.000194	0.000235	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—KNG1—atherosclerosis	0.000192	0.000233	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PPARA—atherosclerosis	0.000191	0.000232	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—UTS2—atherosclerosis	0.000191	0.000232	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AGTR1—atherosclerosis	0.000191	0.000231	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3CG—atherosclerosis	0.00019	0.000231	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IGF1—atherosclerosis	0.000189	0.00023	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000186	0.000226	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SCARB1—atherosclerosis	0.000186	0.000225	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—AGT—atherosclerosis	0.000185	0.000225	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PPARG—atherosclerosis	0.000184	0.000223	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CX3CR1—atherosclerosis	0.000183	0.000222	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CASR—atherosclerosis	0.000183	0.000222	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—APOE—atherosclerosis	0.000182	0.00022	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000181	0.00022	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—INS—atherosclerosis	0.00018	0.000218	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CAV1—atherosclerosis	0.00018	0.000218	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SERPINE1—atherosclerosis	0.00018	0.000218	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CX3CL1—atherosclerosis	0.00018	0.000218	CbGpPWpGaD
Etomidate—SLC2A1—Disease—IL6—atherosclerosis	0.00018	0.000218	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—APOA1—atherosclerosis	0.00018	0.000218	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—ALB—atherosclerosis	0.00018	0.000218	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—EDN1—atherosclerosis	0.000178	0.000216	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CCL5—atherosclerosis	0.000177	0.000214	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—HMGCR—atherosclerosis	0.000176	0.000213	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NOS3—atherosclerosis	0.000172	0.000208	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CNR2—atherosclerosis	0.00017	0.000207	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CXCL8—atherosclerosis	0.00017	0.000207	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—MMP3—atherosclerosis	0.00017	0.000206	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PRKCG—atherosclerosis	0.000168	0.000204	CbGpPWpGaD
Etomidate—SLC2A1—Disease—AKT1—atherosclerosis	0.000166	0.000201	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ALB—atherosclerosis	0.000165	0.0002	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3CG—atherosclerosis	0.000164	0.000199	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000163	0.000197	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—EDN1—atherosclerosis	0.000162	0.000196	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCL5—atherosclerosis	0.000161	0.000195	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000158	0.000192	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PPARG—atherosclerosis	0.000158	0.000192	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—NOS3—atherosclerosis	0.000158	0.000191	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ABCA1—atherosclerosis	0.000157	0.00019	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—INS—atherosclerosis	0.000155	0.000188	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	0.000153	0.000186	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PRKCG—atherosclerosis	0.000153	0.000185	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VWF—atherosclerosis	0.000152	0.000184	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APOC3—atherosclerosis	0.000151	0.000183	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—LDLR—atherosclerosis	0.00015	0.000182	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AGT—atherosclerosis	0.000148	0.000179	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCL3—atherosclerosis	0.000147	0.000178	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTGS2—atherosclerosis	0.000144	0.000175	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ALB—atherosclerosis	0.000142	0.000173	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NCF1—atherosclerosis	0.00014	0.00017	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—AKT1—atherosclerosis	0.000139	0.000168	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—F2—atherosclerosis	0.000137	0.000166	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—NOS3—atherosclerosis	0.000136	0.000165	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—HMOX1—atherosclerosis	0.000134	0.000163	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AGT—atherosclerosis	0.000134	0.000163	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCR2—atherosclerosis	0.000133	0.000161	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EDNRA—atherosclerosis	0.000133	0.000161	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CYBA—atherosclerosis	0.000132	0.00016	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000131	0.000159	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PLAT—atherosclerosis	0.000129	0.000157	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PARP1—atherosclerosis	0.000129	0.000157	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GHRL—atherosclerosis	0.000129	0.000157	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APOB—atherosclerosis	0.000129	0.000156	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTM1—atherosclerosis	0.000125	0.000152	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTGS2—atherosclerosis	0.000124	0.000151	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—F2—atherosclerosis	0.000124	0.00015	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—VEGFA—atherosclerosis	0.000124	0.00015	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—LPL—atherosclerosis	0.000123	0.000149	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GPX1—atherosclerosis	0.00012	0.000145	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PIK3CG—atherosclerosis	0.000119	0.000144	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—MAPK3—atherosclerosis	0.000117	0.000142	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CD36—atherosclerosis	0.000117	0.000141	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TGFB1—atherosclerosis	0.000114	0.000138	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KNG1—atherosclerosis	0.000113	0.000137	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AGTR1—atherosclerosis	0.000113	0.000137	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—MTHFR—atherosclerosis	0.000111	0.000134	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCL2—atherosclerosis	0.000111	0.000134	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PLG—atherosclerosis	0.00011	0.000133	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PPARA—atherosclerosis	0.000109	0.000132	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—AGT—atherosclerosis	0.000105	0.000127	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SOCS3—atherosclerosis	0.000104	0.000126	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APOE—atherosclerosis	0.000103	0.000125	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CAV1—atherosclerosis	0.000102	0.000124	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APOA1—atherosclerosis	0.000102	0.000123	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MMP3—atherosclerosis	0.0001	0.000122	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IGF2—atherosclerosis	0.0001	0.000121	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APOB—atherosclerosis	9.71e-05	0.000118	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CXCL8—atherosclerosis	9.63e-05	0.000117	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EDN1—atherosclerosis	9.56e-05	0.000116	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCL5—atherosclerosis	9.48e-05	0.000115	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3CG—atherosclerosis	9.29e-05	0.000113	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—LPL—atherosclerosis	9.27e-05	0.000112	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PRKCG—atherosclerosis	9.02e-05	0.000109	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PPARG—atherosclerosis	8.97e-05	0.000109	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—INS—atherosclerosis	8.8e-05	0.000107	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SPP1—atherosclerosis	8.78e-05	0.000106	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CXCL8—atherosclerosis	8.74e-05	0.000106	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PDGFB—atherosclerosis	8.13e-05	9.85e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ALB—atherosclerosis	8.06e-05	9.78e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AGT—atherosclerosis	7.93e-05	9.62e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—AKT1—atherosclerosis	7.9e-05	9.57e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—LEP—atherosclerosis	7.77e-05	9.42e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APOE—atherosclerosis	7.77e-05	9.42e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NOS3—atherosclerosis	7.71e-05	9.35e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CAV1—atherosclerosis	7.7e-05	9.34e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APOA1—atherosclerosis	7.68e-05	9.32e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ESR1—atherosclerosis	7.42e-05	9e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—F2—atherosclerosis	7.33e-05	8.89e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—AKT1—atherosclerosis	7.26e-05	8.8e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTGS2—atherosclerosis	7.06e-05	8.55e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PIK3CG—atherosclerosis	7.02e-05	8.5e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—MAPK3—atherosclerosis	6.72e-05	8.14e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—INS—atherosclerosis	6.64e-05	8.05e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCL2—atherosclerosis	6.53e-05	7.92e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IGF1—atherosclerosis	6.42e-05	7.79e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—AKT1—atherosclerosis	6.26e-05	7.59e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SERPINE1—atherosclerosis	6.1e-05	7.39e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOS3—atherosclerosis	5.82e-05	7.06e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCL8—atherosclerosis	5.17e-05	6.26e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AKT1—atherosclerosis	4.99e-05	6.05e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL6—atherosclerosis	4.91e-05	5.95e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MMP9—atherosclerosis	4.67e-05	5.66e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	4.62e-05	5.6e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	4.54e-05	5.51e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	4.53e-05	5.49e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	4.2e-05	5.09e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	4.15e-05	5.04e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	3.97e-05	4.81e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	3.85e-05	4.67e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—AKT1—atherosclerosis	3.55e-05	4.3e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL6—atherosclerosis	2.9e-05	3.52e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	2.68e-05	3.25e-05	CbGpPWpGaD
